Asia Pacific College of Advanced Studies College Department Gec Sts
Asia Pacific College of Advanced Studies College Department Gec Sts
Asia Pacific College of Advanced Studies College Department Gec Sts
Gene Therapy
❖ an experimental technique that uses genes to treat or prevent disease. In the future, this
technique may allow doctors to treat a disorder by inserting a gene into a patient's cells
instead of using drugs or surgery.
❖ It is a technique for correcting defective genes responsible for disease development.
Gene
❖ Basic unit of heredity
❖ Carried on a chromosome
❖ Encode how to make a protein: DNA RNA proteins
❖ Proteins carry out most of life’s function
❖ Causes dysfunction of a protein when altered
How it started?
❖ In the 1980s, Scientists began to look into gene therapy.
❖ They would insert human genes into a bacteria cell.
❖ Then the bacteria cell would transcribe and translate the information into a protein
❖ Then they would introduce the protein into human cells
2. In vivo gene therapy:- direct delivery of genes into the cells of a particular tissue in
the body.
Success depends on:
❖ efficiency of the uptake of the therapeutic gene by the target cells
❖ intracellular degradation of the gene and its uptake by nucleus
❖ the expression capability of the gene
Medicine- one example of a scientific and technological innovation that made a breakthrough
in the area of human health.
Before aspirin was ever understood at the nano level, it had been known for its effects.
Pain of various forms could be relieved and softened by this medicine. The aspirin was already
an ‘old’ technology at the beginning of the 21st century. The more recent findings in the areas
of nano and gene science can be incorporated into medicine.
Manila, Philippines---In recent years, it’s common to hear beauty doctors in the Philippines
offering stem cell therapy as if it is a newfound medical fountain of youth, the answer to all
medical worries.
In various media platform, there are bombardment of advertisements from various hospitals
and clinics packaging stem cell therapy as “cure-all” remedy
With such a medical breakthrough, it begs the question on how equipped we are in offering
such services. We can't help but ask the parameters on distinguishing the real experts from
seemingly fly-by-night clinics and medical centers.
“Be careful. Number one, stem-cell therapy is not a ’cure-all’ (medical procedure).” he said
in an interview with the INQUIRER a few weeks after receiving the 2012 Presidential Award
for Filipino Individuals and Organizations Overseas at the Malacañang Palace.
“The goal of stem-cell therapy is not a longevity-anti-aging program. Stem cell therapy is
actually trying to allow the body to heal itself,” he said.
Educated at Johns Hopkins’ and Harvard Medical School, Dr. Bernal is currently Professor
Emeritus of Medicine at the University of California-Los Angeles, member of American
Association of Clinical Oncologists, the American Association of Cancer Researchers, and a
recognized cancer investigator with the US National Institutes of Health.
As a lawyer, his legal expertise includes cases on medical malpractice, medical product
liability, as well as Federal Drug Administration (FDA) and Federal trade Commission’s
(FTC) regulations in the testing, approval, advertising, and marketing of health products.
He explained stem cell treatment requires “analyzing at the molecular level what is causing
the problem or (what could be done) to prevent the problem.”
“Stem cells are just a small part of the molecular approach to medicine.”
Suppose scientists would like to fashion a gene to counter cancer cell growth. After several
steps of developing the technology, its success would still depend on its science and
implementation. To achieve the goal, the harmful gene has to be found among the 46 such
structures in the ordinary cells of the person. The specific part of the gene doing the problem
should be identified. Afterwards, that section of the gene must be removed and replaced with
the “correct” or developed gene part to complete the therapy. This process would then correct
the misinformation encoded in the whole gene.
The financial cost of this therapy is not trivial. Each of the steps mentioned requires expertise
and technological skill. Therefore, gene therapy can be costly.
Current Status
❖ FDA hasn’t approved any human gene therapy product for sale
Reasons:
❏ In 1999, 18-year-old Jesse Gelsinger died from multiple organ failure 4 days after
treatment for ornithine transcarbamylase deficiency.
★ Death was triggered by severe immune response to adenovirus carrier
❏ January 2003, halt to using retrovirus vectors in blood stem cells because children
developed leukemia-like condition after successful treatment for X-linked severe
combined immunodeficiency disease
❖ Short Lived
❖ Immune Response
❖ Viral Vectors
❖ Multigene Disorders
❖ May induce a tumor if integrated in a tumor suppressor gene because insertional
mutagenesis
References:
a. Science, Technology, and Society by Daniel Joseph McNamara, SJ, Vida Mia
Valverde and Ramon Beleno III.